Phathom Pharmaceuticals (PHAT) Earnings Date & Reports

A.I. Advisor

published Earnings

PHAT is expected to report earnings to fall 5.77% to -147 cents per share on November 06

Phathom Pharmaceuticals PHAT Stock Earnings Reports

Q3'24

Est.

$-1.47

Q2'24

Missed

by $0.24

Q1'24

Beat

by $0.09

Q4'23

Beat

by $0.27

Q3'23

Beat

by $0.13

The last earnings report on August 08 showed earnings per share of -155 cents, missing the estimate of -132 cents. With 961.08K shares outstanding, the current market capitalization sits at 1.20B.

View a ticker or compare two or three

Compare

PHAT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PHAT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PHAT (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

100 Campus Drive

Phone

+1 877 742-8466

Employees

452

Web

https://www.phathompharma.com